Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety and Efficacy of HGT-1110 in Metachromatic Leukodystrophy (Extension of HGT-MLD-070)
NCT01887938Phase 2Completed
- Sponsor
- Takeda
- Start
- May 2013
- Primary completion
- Feb 2026
- Modality
- Replacement Enzymes
- Countries
- 7
01
Overview
A Phase 2 trial of cebsulfase alfa in metachromatic leukodystrophy (MLD), sponsored by Takeda. Started May 2013; status: completed.
02
Drugs
cebsulfase alfa
03
Conditions
metachromatic leukodystrophy (MLD)
Beyond the preview
Go deeper on NCT01887938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01887938.